BALA CYNWYD, Pa., Nov. 1, 2007 (PRIME NEWSWIRE) -- Duska Therapeutics, Inc. (OTCBB:DSKA), a biopharmaceutical company developing new medicines to treat cardiovascular diseases, today announced that it has hired RedChip Companies, Inc. to lead its public and investor relations programs. In addition, Duska Therapeutics, Inc. will be presenting at the RedChip Florida Small-Cap Investor Conference, at the Hyatt Regency Grand Cypress Hotel in Orlando, Fla. James S. Kuo, M.D., M.B.A., the Chairman and Chief Executive Officer of Duska Therapeutics, Inc., will deliver the Company’s presentation Nov. 3, 2007 at 1:45 p.m.
